Rockwell Medical Technologies Closes $20 Million Debt Financing

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Rockwell Medical Receives $20 Million in New Financing

WIXOM, MI--(Marketwired - June 18, 2013) - Rockwell Medical (NASDAQ:

Trigemina Attracts $4.5 Million Funding From Current Investors and Chilean Government Grant

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORAGA, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced...

Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal

Fri, 14 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH EASTON, Mass., June 14, 2013 /PRNewswire/ --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"...

PRISM Pharma Closes $15 Million Series C Financing

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications

YOKOHAMA, Japan, June 13, 2013

Anacor Pharmaceuticals, Inc. Secures $45 Million Loan Facility

Wed, 12 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ: ANAC) announced today that it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules) for...

Dermira Raises $35 Million

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dermira Raises $35m to Fund Innovation in Dermatology

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Dermira, a development-stage biotechnology company focused on developing...

Biologics, Inc. (NC) Helps Cancer Patients Secure Over $7 Million in Copay Assistance in First Quarter

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARY, N.C.--(BUSINESS WIRE)--Biologics, an integrated oncology services company, is pleased to announce that its Patient Access Services team was able to secure over $7 million in copay assistance for patients...

Collbio Limited Raises ??250K to Further Develop Collagen Sales

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Glasgow, June 9 2013: Collbio, a new company set up in March this year by leading life science financiers Diagnostic Capital Ltd, together with former senior management team members Stewart White and Ross Andrews...

Enzo Biochem Enters Into $8.0 Million Senior Secured Revolving Credit Facility With

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has arranged an $8 million senior secured revolving line of credit that may be increased to $12 million with Healthcare Finance...

BioTime Closes on $9 Million Financing

Mon, 10 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BioTime, Inc. Closes on $9 Million Financing

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it...

AbbVie Jumps Into $11.4 Million Series B for Avaxia Biologics, Inc.

Fri, 07 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Avaxia Biologics Closes Series B Financing with Total Proceeds of $11.4 Million

LEXINGTON, Mass.--(BUSINESS WIRE)-- Avaxia Biologics, Inc., a clinical-stage biopharmaceutical...

BioTime Closes on $9 Million Financing

Fri, 07 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it announced on June 3, 2013 and received gross proceeds of $9,057,966.

Help...

Bill & Melinda Gates Foundation Joins $35 Million Funding in Startup the of Scientists

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Microsoft Corp. (MSFT) co-founder Bill Gates, the worlds richest person, is helping lead a $35 million investment in ResearchGate, a networking website for scientists.

Gates is joining Tenaya Capital...

Trinean nv Secures $1 Million Euro Financing

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ghent, Belgium May 30, 2013 - Trinean, the leading provider of microfluidic spectrophotometry platforms, announced today to have secured a 1 million euro investment in a second closing of its 3.7 million...

Targovax AS Raises $3.6 Million in Private and Public Support for TG01 Pancreatic Cancer Vaccine Development

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

OSLO, Norway--(BUSINESS WIRE)--Cancer vaccine specialist Targovax today announced that it has raised a total of $3.6 million to accelerate development of its RAS mutation-targeted therapeutic cancer vaccine...

Array BioPharma, Inc. Prices Upsized $115 Million Convertible Offering

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Array BioPharma Announces Pricing of Public Offering of $115 Million of Convertible Senior Notes

BOULDER, Colo., June 4, 2013 /PRNewswire...

Targovax AS Raises $3.6 Million in Private and Public Support for TG01 Pancreatic Cancer Vaccine Development

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

(Oslo, June 6, 2013) Cancer vaccine specialist Targovax today announced that it has raised a total of $3.6 million to accelerate development of its RAS mutation-targeted therapeutic cancer vaccine pipeline...

ARCA biopharma Announces Closing of $20 Million Equity Offering

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced the closing of the...

Protagonist Therapeutics Pulls in $14 Million, Led by Johnson & Johnson, for Peptide Pills

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Protagonist Therapeutics Raises $14 Million in Series B Venture Financing

MENLO PARK, Calif., June 4, 2013 /PRNewswire/ --

Akebia Therapeutics, Inc. Closes $41 Million Series C

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Proceeds to Support Phase 2b Trial and Phase 3 Preparations for Promising Anemia Drug Candidate--

Akebia Therapeutics, a biotech company focused on developing and commercializing small molecules to...

Edge Therapeutics Banks $18 Million

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Edge Therapeutics Raises $18 Million to Advance Clinical Development of Potentially Life-Saving Hospital Products

NEW PROVIDENCE, NJ--(Marketwired...

StemCells Inc. Secures $30 Million Financing Commitment From

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEWARK, Calif., June 4, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research...

BioTime to Raise $9 Million in Registered Direct Offering

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that it has agreed to sell up to an aggregate of 2,180,016 common shares and 545,004 warrants to purchase common shares, in units...

InVivo Therapeutics Corporation Raises $16.1 Million From Warrant Call

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

InVivo Therapeutics Raises $16.1 Million from Warrant Call and Exercises Paving Way for Up-Listing to a National Securities Exchange

CAMBRIDGE, Mass.--(BUSINESS WIRE...

Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, June 3, 2013 /PRNewswire/ -- Arcturus Therapeutics...

Ontario Bioscience Innovation Organization: New Program to Bridge Funding Gap for Life Sciences Companies Gets Financial Boost From Ontario

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--An industry-led program in Ontario that works to improve access to capital for human health technology and bioscience companies has received a major financial boost from the province...

BerGenBio AS Secures Additional $6 Million as First in Class AXL Kinase Inhibitor BGB324 Approaches Clinic

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Bergen, May 29, 2013, BerGenBio, an emerging oncologybiopharma, today announced that it has secured an additional $6 million from existing investors , Investinor, Sarsia Seed, Birk Venture, RO Invest and Meteva...

Ophthotech Corporation Nabs $175 Million to Fund Late-Stage Trial for Eye Drug

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista Anti-PDGF Combination Therapy in Wet AMD

NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation...

Arcato Laboratories Announces Execution of Term Sheet for Series A Round of Financing

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GREENSBORO, North Carolina May 29, 2013 -- Arcato Laboratories, Inc., an emerging oral health company, announced today that it has executed a term sheet with Piedmont Angel Network (PAN), who will lead the...

Trino Therapeutics Secures $12 Million in Series A Investment

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cobra Biologics and Recopharma Enter agreement to utilise Cobras Cell Line Development Service- MaxXpress

28 May 2013 -- DUBLIN, IRELAND: May 28th 2013, TRINO THERAPEUTICS...

Immunotech Laboratories Signs Funding Agreement With

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MONROVIA, Calif., May 28, 2013 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. (Pink Sheets:IMMB) Immunotech Laboratories, Inc. today released the following company updates for shareholders and Investors...

TRANSGENE Announces a Follow-on Investment in Jennerex, Inc.

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene SA (Paris:TNG), a biopharmaceutical company that develops immunotherapy products to treat major unmet medical needs in cancer and chronic infectious...

ugichem GmbH Receives $2.6 Million Funding for Antisense Drug Platform

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ugichem receives 2.25 million funding for antisense drug platform

Innsbruck, Austria, 28 May 2013 ugichem GmbH, developer of a novel antisense drug platform, has raised...

Tauriga Sciences Inc. Completes $225,000 Private Placement With New York City Based Institutional Investor

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 24, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"), a life sciences company creating a diversified portfolio of medical technology assets, novel medical...

Cardeas Pharma Snags $34 Million for Antibiotic Against Hospital Infections

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Seattle-based Cardeas Pharma just raised a lot more cash to fight a big problem that hospitals wrestle with every day, and which theyd rather not say much about publicly. Cardeas, the startup led by prolific...

Jennerex, Inc. Completes $21.6 Million Private Placement

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Jennerex Completes $21.6 Million Private Placement

SAN FRANCISCO, CA--(Marketwired - May 23, 2013) - Jennerex Biotherapeutics, Inc., a...

Phagenesis Ltd Expands Series B Financing to $17 Million

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Phagenesis Expands Series B Financing to $17 million

MANCHESTER, England--(BUSINESS WIRE)-- Phagenesis, the worlds leading company in the treatment of dysphagia, has...

OLIGOMERIX Completes Series B Financing

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 22, 2013 /PRNewswire/ -- Oligomerix, Inc....

TRANSGENE Announces its Invesment in a New Antibody Company Created by Former Executives

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene SA (Euronext Paris: TNG)(Paris:TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs...

Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

eFFECTOR Therapeutics Raises $45 Million in Series A Financing

SAN DIEGO, May 20, 2013 /PRNewswire/ -- eFFECTOR Therapeutics, a newly...

Karyopharm Therapeutics Raises $48.2 Million in Series B Financing

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Karyopharm Therapeutics Raises $48.2 Million in Series B Financing

NATICK, Mass., May 20, 2013 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc., a leader in the new...

Merck KGaA Ups Commitment to MS Ventures to $129 Million

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Merck Increases Its Commitment to MS Ventures to 100 million

Darmstadt, Germany, May 16, 2013 - Merck announced today that it will increase its commitment to its strategic...

The Start-Up a New Player in the Therapeutic Monoclonal Antibody Arena, Announces the First Round of Financing With TRANSGENE and

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LYON, France & ILLKIRCH-GRAFFENSTADEN, France--(BUSINESS WIRE)--ElsaLys Biotech, which specializes in the development of therapeutic monoclonal antibodies, announces a first round of financing of 2.1M from...

Tokai Pharmaceuticals Raises $35.5 Million for Prostate Cancer Study

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Tokai Pharmaceuticals Announces $35.5 Million Series E Financing

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments...

Kite Pharma, Inc. Locks in $20 Million From Big Investors

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kite Pharma Completes $35 Million Series A Preferred Stock Financing

LOS ANGELES, May 15, 2013 /PRNewswire/ -- Kite Pharma Inc. (Kite), a clinical stage...

Karyopharm Therapeutics Gets $20.5 Million

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Clinical-stage biopharma Karyopharm Therapeutics has secured $20.5 million of a $60 million offering. Its the second round of funding received by the Natick, Mass. developer of cancer- and inflammation-targeting...

Callidus Biopharma Announces $4.6 million in Series A Financing to Pursue Orphan Disease Therapies

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DOYLESTOWN, Pa., May 14, 2013 /PRNewswire/ -- Callidus Biopharma, Inc., a development-stage biotechnology company...

National Institutes of Health (NIH) Budget Gets Slashed by $1.55 Billion in 2013; Scientists React

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

After weeks of worrying about how the mandatory across-the-board 2013 budget cuts known as the sequester would play out at the National Institutes of Health (NIH), the biomedical research community now has final...

Dyax Corp. Announces $30 Million Offering

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dyax Corp. Announces $30 Million Offering

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that it has priced a registered direct offering with RA Capital Management...

Frazier Healthcare Inches Closer to $300 Million Biotech Fund

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 10, 2013 -- According to a SEC Filing, Frazier Healthcare VII, LP (FH VII) has almost reached its goal. The firm has a combined targeted offering amount of $300M of which commitments totaling $281.8M have...

Lumena Pharmaceuticals Raises $23 Million to Advance Drug for Rare Liver Diseases

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Lumena Pharmaceuticals, a company developing oral therapeutics for rare...

Alimera Sciences Secures $20 Million Debt Facility

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ATLANTA, May 8, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization...

Zalicus Inc. Enters $25 Million Committed Funding Agreement

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that...

Cardio3 BioSciences Raises $24.9 Million Through a Private Placement

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MONT-SAINT GUIBERT, Belgium, May 8, 2013 /PRNewswire/ -- The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative, protective and reconstructive...

Ex-Pfizer Inc. and Lipitor Drug Developer Closes $33 Million New Cholesterol Drug